Immunovia
IMMNOV | ST
Overview
Corporate Details
- ISIN(s):
- SE0006091997 (+2 more)
- LEI:
- 549300KHWL6KK1XGUO81
- Country:
- Sweden
- Address:
- Scheelevägen 8, 223 63 LUND
- Website:
- https://immunovia.com/
- Sector:
- Health Care
- Industry:
- Health Care Technology
Description
Immunovia AB is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s proprietary test platform called IMMray™. Tests are based on antibody biomarker microarray analysis using advanced machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a unique “disease biomarker signature”. The company was founded in 2007, based on cancer studies and ground-breaking research in the Department of Immuntechnology at Lund University and CREATE Health Cancer Center, Sweden. The first product, IMMray™ PanCan-d, is undergoing clinical evaluation in some of the world’s largest clinical studies for high risk groups in pancreatic cancer, PanFAM-1, PanSYM-1 and PanDIA-1.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-14 15:45 |
Declaration of Voting Results & Voting Rights Announcements
KOMMUNIKÉ FRÅN ÅRSSTÄMMA DEN 14 MAJ 2025 I IMMUNOVIA AB (PUBL)
|
Swedish | 51.3 KB | |
| 2025-05-14 15:45 |
Declaration of Voting Results & Voting Rights Announcements
BULLETIN FROM THE ANNUAL GENERAL MEETING ON 14 MAY 2025 IN IMMUNOVIA AB (PUBL)
|
English | 51.7 KB | |
| 2025-05-14 08:30 |
Quarterly Report
|
Swedish | 2.3 MB | |
| 2025-05-14 08:30 |
Quarterly Report
|
English | 2.3 MB | |
| 2025-05-07 10:37 |
Inside Information Statement
|
English | 10.7 KB | |
| 2025-05-02 15:46 |
Inside Information Statement
|
English | 10.7 KB | |
| 2025-05-02 10:53 |
Inside Information Statement
|
English | 10.7 KB | |
| 2025-04-30 09:45 |
Regulatory News Service
Change in number of shares and votes in Immunovia AB (publ)
|
English | 47.1 KB | |
| 2025-04-30 09:45 |
Regulatory News Service
Ändring av antalet aktier och röster i Immunovia AB (publ)
|
Swedish | 47.7 KB | |
| 2025-02-26 10:22 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 9.2 KB | |
| 2025-02-25 08:30 |
Earnings Release
|
Swedish | 2.1 MB | |
| 2025-02-25 08:30 |
Annual Report
|
English | 2.1 MB | |
| 2025-02-21 16:30 |
Board/Management Change
Immunovia initiates search for a new CFO to support commercialization in the USA
|
English | 125.1 KB | |
| 2025-02-21 16:30 |
Board/Management Change
Immunovia inleder rekrytering efter en ny CFO inför kommersialisering i USA
|
Swedish | 126.1 KB | |
| 2025-01-31 10:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Immunovia AB (publ)
|
English | 187.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-03 | michael Lofman | Other | Sell | 587,532 | 1,292,570.40 SEK |
| 2023-06-07 | Jeffrey Borcherding | Other | Buy | 350,000 | 61,810.00 USD |
| 2023-04-06 | Hans Johansson | Other | Buy | 14,924 | 99,990.80 SEK |
| 2023-03-28 | Martin Moeller | Other | Other | 1,408 | 9,433.60 SEK |
| 2022-11-15 | Philipp Mathieu | Other | Buy | 150,000 | 297,000.00 SEK |
| 2022-05-24 | Jeffrey Borcherding | Other | Buy | 100,000 | 150,000.00 SEK |
| 2022-02-22 | Peter Andersen | Other | Buy | 6,000 | 186,000.00 SEK |
| 2021-09-02 | Martin Moeller | Other | Buy | 1,056 | 141,292.80 SEK |
| 2021-05-28 | Patrik Dahlen | Other | Buy | 6,860 | 675,984.40 SEK |
| 2021-05-07 | Peter Andersen | Other | Buy | 2,730 | 297,570.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Revenio Group Oyj | Finland | REG1V | |
|
Telemedycyna Polska Spolka Akcyjna | Poland | TMP | |
|
TISSUE REGENIX GROUP PLC | United Kingdom | TRX | |
|
TRELLUS HEALTH PLC | United Kingdom | TRLS | |
|
VERICI DX PLC | United Kingdom | VRCI | |
|
Vidavo S.A. | Greece | VIDAV | |
|
ViroGates A/S | Denmark | VIRO | |
|
Xvivo Perfusion | Sweden | XVIVO | |
|
Yoshi Innovation Spolka Akcyjna | Poland | YOS |